Companies / BOC Sciences / Urabrelimab
BOC Sciences

Urabrelimab | BOC Sciences

Urabrelimab is a humanized anti-CD47 monoclonal antibody. Urabrelimab binds to CD47 and inhibits CD47-SIRP_ interaction. Urabrelimab exerts antitumor activity in vitro through both phagocytosis and cell death in a manner dependent on the activating Fc-gamma receptor (Fc_R), CD32a.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.